| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098225 Compositions and Methods for Reduction of LDL Oxidation |
| 04/16/2009 | US20090098201 Composition and Method for Treatment and Prevention of Atherosclerosis |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098097 Composition for normalizing blood pressure |
| 04/16/2009 | US20090098096 Agent for correcting stress-inducing neuro-mediator, neuro-endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions |
| 04/16/2009 | DE102007049157A1 New substituted 2,3-dihydro-(1,2,3)triazol-4-one compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, inflammatory disease and anemia |
| 04/16/2009 | DE102007048447A1 New substituted dihydropyrazole-3-thione compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, wound healing and anemia |
| 04/16/2009 | CA2702265A1 Novel seh inhibitors and their use |
| 04/16/2009 | CA2702173A1 Preparation for treating heart disease used in cell therapy |
| 04/16/2009 | CA2702111A1 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 04/16/2009 | CA2702045A1 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine |
| 04/16/2009 | CA2702008A1 Inhibitors of protein kinases |
| 04/16/2009 | CA2699257A1 Cgrp as a therapeutic agent |
| 04/16/2009 | CA2699169A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 04/16/2009 | CA2699168A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 04/16/2009 | CA2699163A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | CA2699088A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | CA2699084A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent |
| 04/16/2009 | CA2699083A1 Use of a peptide as a therapeutic agent |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2048138A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 04/15/2009 | EP2047866A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 04/15/2009 | EP2047859A1 Treatment of ischemic disease using erythropoietin |
| 04/15/2009 | EP2047853A1 The application of marine steroid in preparing the medicine of treating neurons damaging |
| 04/15/2009 | EP2046948A1 Activated fibroblasts for treating tissue and/or organ damage |
| 04/15/2009 | EP2046834A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 04/15/2009 | EP2046804A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 04/15/2009 | EP2046791A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 04/15/2009 | EP2046759A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 04/15/2009 | EP2046756A2 Preparation of telmisartan salts |
| 04/15/2009 | EP2046748A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 04/15/2009 | EP2046722A2 Beta-3 receptor ligands and their use in therapy |
| 04/15/2009 | EP2046349A1 Treatment of excessive neovascularization |
| 04/15/2009 | EP2046348A2 Use of poloxamer for the prevention and/or treatment of heart failure |
| 04/15/2009 | EP2046333A2 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 04/15/2009 | EP2046329A2 Soluble epoxide hydrolase inhibitors |
| 04/15/2009 | EP2046327A1 Medical use of cyclin dependent kinases inhibitors |
| 04/15/2009 | EP2046312A2 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 04/15/2009 | EP1861092A4 Potassium channel opener having benzofuroindole skeleton |
| 04/15/2009 | EP1812430B1 Substituted phenylaminothiazoles and use thereof |
| 04/15/2009 | EP1797881B1 Medicinal composition with improved stability and reduced gelation properties |
| 04/15/2009 | EP1640039B1 Adjustable, non-electric liquid air-freshener device |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1480678B1 Treatment of ophthalmic disorders using urea and urea derivatives |
| 04/15/2009 | EP1458677B1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/15/2009 | EP1437140B1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 04/15/2009 | EP1423115B1 Antiangiogenic activity of nitrogen substituted thalidomide analogs |
| 04/15/2009 | EP1417307B1 Oligonucleotide compositions and their use to induce apoptosis |
| 04/15/2009 | EP1414523B1 Use of a lactate salt for the treatment and prophylaxis of atherosclerosis |
| 04/15/2009 | EP1399109B1 Separation of platelets from whole blood for use as wound healants |
| 04/15/2009 | EP1378246B1 sPLA2 INHIBITORS FOR ARTERIOSCLEROSIS |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1267882B1 Prostaglandins for the treatment of eye disease caused by light irradiation like photoretinitis |
| 04/15/2009 | EP1257295B1 Factor vii or viia-like molecules |
| 04/15/2009 | EP1203007B1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) and its receptor c-met |
| 04/15/2009 | EP1151753B1 Preventive and therapeutic agents for arteriosclerosis |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410389A Organic compounds |
| 04/15/2009 | CN101410385A Benzothiazoles having histamine H3 receptor activity |
| 04/15/2009 | CN101410370A Selective hydroxamate based MMP inhibitors |
| 04/15/2009 | CN101410130A Novel immunomodulating peptide |
| 04/15/2009 | CN101410126A MAPC therapeutics without adjunctive immunosuppressive treatment |
| 04/15/2009 | CN101410125A MAPC treatment of brain injuries and diseases |
| 04/15/2009 | CN101410110A Varenicline standards and impurity controls |
| 04/15/2009 | CN101410107A MIF inhibitors |
| 04/15/2009 | CN101407812A Heterologous expression and purification method for human RANTES protein having chemotaxis |
| 04/15/2009 | CN101407811A Dairy-derived antihypertensive 7 peptide tandem gene and method for synthesizing the same |
| 04/15/2009 | CN101407810A Small interfering RNA with midkine gene as target, vector and use thereof |
| 04/15/2009 | CN101407558A Preparation of Dendrobium nobile polysaccharide extract and use there |
| 04/15/2009 | CN101407557A Preparation and use of Dendrobium nobile polysaccharide extract |
| 04/15/2009 | CN101407511A Crystal type glyoxaline-5-carboxyl acid derivative |
| 04/15/2009 | CN101407495A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101407494A Preparations and uses of isoquinolinium compounds and salts thereof |
| 04/15/2009 | CN101406693A Use of pharmaceutical composition for treating cardiovascular disease in preparing medicament for protecting endothelial cell damage |
| 04/15/2009 | CN101406683A Chinese medicine compound and preparation method thereof |
| 04/15/2009 | CN101406673A Oral liquid special for treating vital myocarditis of children |
| 04/15/2009 | CN101406672A Chinese medicinal liquor for treating hypertension and preparation method thereof |
| 04/15/2009 | CN101406671A Chinese medicament preparation for treating cardiac extra systole |
| 04/15/2009 | CN101406666A Chinese medicine for treating coronary heart disease and angina pectoris, and preparation method and use thereof |
| 04/15/2009 | CN101406630A Medicament for treating coronary heart disease |
| 04/15/2009 | CN101406621A Medicinal liquor for treating sequelae of cerebral thrombus |
| 04/15/2009 | CN101406613A Use of Chinese medicinal composition in preparing medicament for treating vital myocarditis |
| 04/15/2009 | CN101406587A Oral medicament for treating hemorrhoid |
| 04/15/2009 | CN101406574A Chinese medicine decoction for treating cardiopathy |
| 04/15/2009 | CN101406569A Chinese medicinal composition for treating cerebrovascular disease, and preparation thereof |
| 04/15/2009 | CN101406527A Method for preparing salts of Corydalis ambigua total alkaloid and use thereof as medicament for treating cardiovascular disease |
| 04/15/2009 | CN101406513A Malaytea scurfpea fruit extract, pharmaceutical composition containing the same, and preparation method and application thereof |
| 04/15/2009 | CN101406504A Method for extracting flavone substances in jumi |
| 04/15/2009 | CN101406495A Medicament for mainly curing cardiovascular disease |
| 04/15/2009 | CN101406478A Pharmaceutical composition for reducing homosysteine |
| 04/15/2009 | CN101406474A Nalmefene injection and preparation method thereof |
| 04/15/2009 | CN101406472A Pharmaceutical composition of atenolol/amlodipine/folacin compound and uses thereof |
| 04/15/2009 | CN101406466A Cinnamic acid transdermal patch and preparation technique thereof |
| 04/15/2009 | CN101406461A Amlodipine besylate dropping pills and preparation method thereof |
| 04/15/2009 | CN101406282A Blueberry leisure dairy food |
| 04/15/2009 | CN101406230A Method for preparing ball-type bitter gourd tea |
| 04/15/2009 | CN100478351C Extractive of alfalfa, preparation method and usage |